General Range
FORDOXIME-100
Price on request/100 · MOQ 100 boxes
FORDOXIME-100 Dispersible Tablets by Fortune Labs contain Cefpodoxime Proxetil 100 mg, a third-generation cephalosporin antibiotic used to treat infections caused by susceptible bacteria. This medicine works by preventing bacterial cell wall formation, helping eliminate infection-causing bacteria. FORDOXIME-100 may be prescribed for selected respiratory tract infections, throat infections, sinusitis, urinary tract infections, and skin infections when clinically appropriate. Its dispersible formulation provides a convenient administration option under medical guidance. Available in 10 × 10 tablet blister packaging, FORDOXIME-100 is included in Fortune Labs' pharmaceutical product range. Fortune Labs offers distribution and PCD Pharma Franchise opportunities across India. Contact the company for wholesale pricing, product availability, and franchise enquiries. Use only as prescribed by a healthcare professional.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Cefpodoxime Proxetil 100 mg
- Packaging Type
- Blister Pack
- Packaging Size
- 10 × 10
- Dosage Form
- Tablet
- Treatment
- Bacterial respiratory tract infections, throat infections, sinusitis, ear infections, urinary tract infections, and certain skin infections.
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
